Kymab, a Sanofi Company, Babraham Research Campus, Cambridge, United Kingdom.
Department of Statistics, University of Oxford, Oxford, United Kingdom.
Elife. 2023 Mar 27;12:e81629. doi: 10.7554/eLife.81629.
Immunoglobulin loci-transgenic animals are widely used in antibody discovery and increasingly in vaccine response modelling. In this study, we phenotypically characterised B-cell populations from the Intelliselect Transgenic mouse (Kymouse) demonstrating full B-cell development competence. Comparison of the naïve B-cell receptor (BCR) repertoires of Kymice BCRs, naïve human, and murine BCR repertoires revealed key differences in germline gene usage and junctional diversification. These differences result in Kymice having CDRH3 length and diversity intermediate between mice and humans. To compare the structural space explored by CDRH3s in each species' repertoire, we used computational structure prediction to show that Kymouse naïve BCR repertoires are more human-like than mouse-like in their predicted distribution of CDRH3 shape. Our combined sequence and structural analysis indicates that the naïve Kymouse BCR repertoire is diverse with key similarities to human repertoires, while immunophenotyping confirms that selected naïve B cells are able to go through complete development.
免疫球蛋白基因座转基因动物被广泛应用于抗体发现,并越来越多地用于疫苗反应建模。在这项研究中,我们对 Intelliselect 转基因小鼠(Kymouse)的 B 细胞群体进行了表型特征分析,证明其具有完全的 B 细胞发育能力。Kymouse BCR、天然人类和天然小鼠 BCR 受体库的比较揭示了在胚系基因使用和连接多样性方面存在关键差异。这些差异导致 Kymice 的 CDRH3 长度和多样性在小鼠和人类之间处于中间位置。为了比较每种物种的 CDRH3 库中探索的结构空间,我们使用计算结构预测来表明,Kymouse 天然 BCR 库在 CDRH3 形状的预测分布上更接近人类,而不是小鼠。我们的综合序列和结构分析表明,天然 Kymouse BCR 库具有多样性,与人类库具有关键相似性,而免疫表型分析证实,所选的天然 B 细胞能够完成整个发育过程。